2024:e2407134
Menores de edad sin supervisin mdica
To administer 2mg (2000mcg): you would draw 200 units (2ml) on a U-100 insulin syringe
A healthcare provider will carefully weigh the potential benefits against the risks, closely monitoring for therapeutic response, side effects, and overall safety
Major population health real-world studies such as SCoMIS, which examines the use of Wegovy in the Scottish population will read-out by 2029, and SURMOUNT-REAL will provide definitive insights into whether use of Obesity Medicines brings healthcare system benefits in the form of, for example, reduced cardiovascular events, diabetes or disability, and may also provide data on wider socio-economic benefits, such as reduced unemployment
Researchers are still studying its long-term safety and effectiveness.[mabrymedical] What should I ask a clinician before using it